Charles River Laboratories (CRL)
Healthcare
Diagnostics & Research
232.50 $
-0.9%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Charles River Laboratories (CRL)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 98.9% of the shares are freely tradable; institutional investors hold 123.4%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
123.4%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
0.6%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
98.9%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
8.0%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
48Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 8.01 | 3,859,100 | +2.8 | 03/31/2026 |
| FMR Inc | 7.18 | 3,456,244 | +99.3 | 03/31/2026 |
| Vanguard Capital Management, LLC | 6.65 | 3,202,204 | +0.0 | 03/31/2026 |
| Amvescap Plc. | 4.98 | 2,397,252 | -11.1 | 03/31/2026 |
| Vanguard Portfolio Management, LLC | 4.76 | 2,294,670 | +0.0 | 03/31/2026 |
| Harris Associates L.P. | 4.47 | 2,153,296 | +28.4 | 03/31/2026 |
| Allspring Global Investments Holdings, LLC | 4.14 | 1,993,316 | -0.1 | 03/31/2026 |
| State Street Corp | 3.89 | 1,873,618 | +0.1 | 03/31/2026 |
| Dimensional Fund Advisors, Inc. | 3.43 | 1,652,484 | +14.6 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Fidelity Contrafund | 3.75 | 1,807,861 | +23.5 | 06/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.